Literature DB >> 10453410

Cardiovascular MR angiography.

M R Prince1, J M Rubin.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10453410     DOI： 10.1023/a:1006219829366

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN： 0167-9899


× No keyword cloud information.
  15 in total

1.  Arterial-phase three-dimensional gadolinium magnetic resonance angiography of the renal arteries. Strategies for timing and contrast media injection: original investigation.

Authors:  S O Schoenberg; M V Knopp; M R Prince; F Londy; M A Knopp
Journal:  Invest Radiol       Date:  1998-09       Impact factor: 6.016

2.  Adverse reactions to gadolinium contrast media: a review of 36 cases.

Authors:  K J Murphy; J A Brunberg; R H Cohan
Journal:  AJR Am J Roentgenol       Date:  1996-10       Impact factor: 3.959

3.  Breath-hold, contrast-enhanced, three-dimensional MR angiography.

Authors:  D A Leung; G C McKinnon; C P Davis; T Pfammatter; G P Krestin; J F Debatin
Journal:  Radiology       Date:  1996-08       Impact factor: 11.105

Review 4.  Three-dimensional contrast-enhanced MR angiography.

Authors:  J H Maki; T L Chenevert; M R Prince
Journal:  Top Magn Reson Imaging       Date:  1996-12

5.  Peripheral vascular tree stenoses: evaluation with moving-bed infusion-tracking MR angiography.

Authors:  K Y Ho; T Leiner; M W de Haan; A G Kessels; P J Kitslaar; J M van Engelshoven
Journal:  Radiology       Date:  1998-03       Impact factor: 11.105

Review 6.  Coronary MR angiography.

Authors:  A J Duerinckx
Journal:  Magn Reson Imaging Clin N Am       Date:  1996-05       Impact factor: 2.266

7.  Time-resolved contrast-enhanced 3D MR angiography.

Authors:  F R Korosec; R Frayne; T M Grist; C A Mistretta
Journal:  Magn Reson Med       Date:  1996-09       Impact factor: 4.668

8.  Bolus-chase MR digital subtraction angiography in the lower extremity.

Authors:  Y Wang; H M Lee; N M Khilnani; D W Trost; M B Jagust; P A Winchester; H L Bush; T A Sos; H D Sostman
Journal:  Radiology       Date:  1998-04       Impact factor: 11.105

9.  Renal tolerance of gadolinium-DTPA/dimeglumine in patients with chronic renal failure.

Authors:  J Haustein; H P Niendorf; G Krestin; T Louton; G Schuhmann-Giampieri; W Clauss; W Junge
Journal:  Invest Radiol       Date:  1992-02       Impact factor: 6.016

10.  Nephrotoxicity of high-dose gadolinium compared with iodinated contrast.

Authors:  M R Prince; C Arnoldus; J K Frisoli
Journal:  J Magn Reson Imaging       Date:  1996 Jan-Feb       Impact factor: 4.813
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.